Ísrael - hebreska - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Ísrael - hebreska - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Ísrael - hebreska - Ministry of Health

tzamal medical ltd - כלל האוכלוסיה - לפי הוראות היצרן

Ísrael - hebreska - Ministry of Health

אודיה תעשיות בעמ - לטיפול בפטמות סדוקות

Ísrael - hebreska - Ministry of Health

אודיה תעשיות בעמ - לטיפול בפיטמות סדוקות לטיפול בעור יבש וסדוק

Ísrael - hebreska - Ministry of Health

inovamed ltd - finasteride - film coated tablets - finasteride - for the treatment and control of benign prostatic hyperplasia (bph) and for the prevention of urologic events to reduce the risk of acute urinary retention.reduce the risk of surgery including transurethral resection of the prostate (turp) and prostatectomy. this product causes regression of the enlarged prostate, improves urinary flow and improves the symptoms assocciated with bph. patients with an enlarged prostate are the appropriate candidates for therapy with this product.

Ísrael - hebreska - Ministry of Health

inovamed ltd - epirubicin hydrochloride - תמיסה להזרקה - epirubicin hydrochloride 2 mg / 1 ml - epirubicin - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma high doses, ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.

Ísrael - hebreska - Ministry of Health

inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 50 mg - bicalutamide - bicalutamide - for the treatment of advanced prostate cancer in combination with luteinising hormone-releasing hormone (lhrh) analog therapy or surgical castration.

Ísrael - hebreska - Ministry of Health

inovamed ltd - anastrozole - טבליות מצופות פילם - anastrozole 1 mg - anastrozole - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.